3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
4
INDUSTRY
3
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
14
Endocrine
14
Thoracic
2
Sarcoma
1
Other solid neoplasm
1
Head & Neck
1
Gastrointestinal
1
Conditions
Mesothelioma, Malignant
6
Solid Tumor
4
Mesothelioma
3
Solid Tumors
2
Pediatric Solid Tumors
2
Advanced Solid Tumor
2
Thymoma
1
Stomach Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Solid Tumor, Adult
1
Retinoblastoma
1
Refractory Solid Tumors
1
Pleural Effusion, Malignant
1
Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Neoplasm Metastasis
1
Malignant Solid Tumor
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Immunoglobulin Light-chain Amyloidosis
1
Heart Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Childhood Solid Tumor
1
Carcinoma, Hepatocellular
1
Interventions
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Neuroendocrine Tumors
×
Other solid neoplasm
×
Clear all
NCT04375267
2026-04-14
LuPARP
Vastra Gotaland Region
Phase 1
Completed
18 enrolled